Browsing by Author Tim R. Cressey

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 64 to 83 of 108 < previous   next >
Issue DateTitleAuthor(s)
10-Jun-2016Pharmacokinetics of once-daily darunavir/ ritonavir with and without etravirine in human immunodeficiency virus-infected children, adolescents, and young adultsKajal B. Larson; Tim R. Cressey; Ram Yogev; Andrew Wiznia; Rohan Hazra; Patrick Jean-Philippe; Bobbie Graham; Amy Gonzalez; Paula Britto; Vincent J. Carey; Edward P. Acosta
1-Mar-2014Pharmacokinetics of pediatric lopinavir/ritonavir tablets in children when administered twice daily according to FDA weight bandsDiane E.T. Bastiaans; Silvia Forcat; Hermione Lyall; Tim R. Cressey; Rawiwan Hansudewechakul; Suparat Kanjanavanit; Antoni Noguera-Julian; Christoph Konigs; Jamie R.J. Inshaw; Suwalai Chalermpantmetagul; Yacine Saidi; Alexandra Compagnucci; Lynda M. Harper; Carlo Giaquinto; Angela P.H. Colbers; David M. Burger
1-Jan-2018Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescentsWatsamon Jantarabenjakul; Suvaporn Anugulruengkitt; Naruporn Kasipong; Narukjaporn Thammajaruk; Jiratchaya Sophonphan; Torsak Bunupuradah; Tim R. Cressey; Angela Colbers; David M. Burger; Wanatpreeya Phongsamart; Thanyawee Puthanakit; Chitsanu Pancharoen
1-Jul-2016Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant WomenAnna H. Tran; Brookie M. Best; Alice Stek; Jiajia Wang; Edmund V. Capparelli; Sandra K. Burchett; Regis Kreitchmann; Kittipong Rungruengthanakit; Kathleen George; Tim R. Cressey; Nahida Chakhtoura; Elizabeth Smith; David E. Shapiro; Mark Mirochnick; Shelley Buschur; Chivon Jackson; Mary Paul; Donna McGregor; Ram Yogev; Rohit Kalra; Claudia Florez; Patricia Bryan; Monica Stone; Andrew D. Hull; Mary Caffery; Stephen A. Spector; Joan Wilson; Julieta Giner; Margaret A. Donnelly; Ellen R. Cooper; Debra A. McLaud; Lisa F. Tucker; Jane Hitti; Amanda Robson-Nuss; Ann J. Melvin; Margaret A. Keller; Michael A. Bolaris; Judy Hayes; Françoise Kamer; La Shonda Spencer; James Homans; Torri Metz; Jenna Wallace; Alisa Katai; Mariam Aziz; Maureen McNichols; Julie Schmidt; Diane Wara; Kristinalisa Maka; Deborah Cohan; Audra Deveikis; Jagmohan Batra; Janielle Jackson Alvarez; Michele Carter; Jaime Deville; Carla Janzen; Jenny Gutierrez; Martha Cavallo; Murli Purswani; Katherine M. Knapp; Nina Sublette; Thomas Wride
28-Nov-2016Pharmacokinetics of unboosted atazanavir in treatment-experienced HIV-infected children, adolescents and young adultsTim R. Cressey; Rohan Hazra; Andrew Wiznia; Marc Foca; Patrick Jean-Philippe; Bobbie Graham; Jennifer R. King; Paula Britto; Vincent J. Carey; Edward P. Acosta; Ram Yogev
1-Jan-2015Pharmacokinetics of vancomycin in critically ill patients in ThailandThitinat Dedkaew; Tim R. Cressey; Baralee Punyawudho; Aroonrut Lucksiri
1-Jan-2013Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected thai childrenTim R. Cressey; Linda Aurpibul; Thition Narkbunnam; Virat Sirisanthana; Wanatpreeya Phongsamart; Peninnah Oberdorfer; Keswadee Lapphra; Tavitiya Sudjaritruk; Kulkanya Chokephaibulkit
1-Feb-2018A phase II/III trial of lopinavir/ritonavir dosed according to the WHO pediatric weight band dosing guidelinesJorge A. Pinto; Edmund V. Capparelli; Meredith Warshaw; Bonnie Zimmer; Tim R. Cressey; Stephen A. Spector; Min Qin; Betsy Smith; George K. Siberry; Mark Mirochnick
1-Jun-2021Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and RaltegravirXiaomei I. Liu; Jeremiah D. Momper; Natella Y. Rakhmanina; Dionna J. Green; Gilbert J. Burckart; Tim R. Cressey; Mark Mirochnick; Brookie M. Best; John N. van den Anker; André Dallmann
1-Dec-2021Pilot evaluation of an enzymatic assay for rapid measurement of antiretroviral drug concentrationsAyokunle O. Olanrewaju; Benjamin P. Sullivan; Ashley R. Bardon; Tiffany J. Lo; Tim R. Cressey; Jonathan D. Posner; Paul K. Drain
1-Jan-2015Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function ImpairmentTim R. Cressey; Anchalee Avihingsanon; Guttiga Halue; Prattana Leenasirimakul; Pra Ornsuda Sukrakanchana; Yardpiroon Tawon; Nirattiya Jaisieng; Gonzague Jourdain; Anthony T. Podany; Courtney V. Fletcher; Virat Klinbuayaem; Chureeratana Bowonwatanuwong
15-May-2008Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected childrenTim R. Cressey; Hannah Green; Saye Khoo; Jean Marc Treluyer; Alexandra Compagnucci; Yacine Saidi; Marc Lallemant; Diana M. Gibb; David M. Burger
29-Jun-2009Plasma efavirenz concentrations and the association with CYP2B6-516G&gt;T polymorphism in HIV-infected Thai ChildrenThanyawee Puthanakit; Pranoot Tanpaiboom; Linda Aurpibul; Tim R. Cressey; Virat Sirisanthana
1-Aug-2020Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarateTim R. Cressey; Oraphan Siriprakaisil; Rachel W. Kubiak; Virat Klinbuayaem; Pra ornsuda Sukrakanchana; Justice Quame-Amaglo; Hideaki Okochi; Yardpiroon Tawon; Ratchada Cressey; Jared M. Baeten; Monica Gandhi; Paul K. Drain
1-Oct-2020Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and PreventionPaul K. Drain; Ashley R. Bardon; Jane M. Simoni; Tim R. Cressey; Pete Anderson; Derin Sevenler; Ayokunle O. Olanrewaju; Monica Gandhi; Connie Celum
1-Apr-2022Point-of-care semi-quantitative test for adherence to tenofovir alafenamide or tenofovir disoproxil fumarateDerin Sevenler; Xin Niu; Sandy Dossantos; Mehmet Toner; Tim R. Cressey; Rebecca D. Sandlin; Paul K. Drain
1-Jan-2016A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based RegimensNontiya Homkham; Tim R. Cressey; Lily Ingsrisawang; Naïm Bouazza; Chaiwat Ngampiyaskul; Suchat Hongsiriwon; Sakulrat Srirojana; Suparat Kanjanavanit; Sorakij Bhakeecheep; Sophie Le Coeur; Nicolas Salvadori; Jean Marc Treluyer; Gonzague Jourdain; Saik Urien
1-Mar-2021Population pharmacokinetics of tenofovir in pregnant and postpartum women using tenofovir disoproxil fumarateAhizechukwu C. Eke; Kensuke Shoji; Brookie M. Best; Jeremiah D. Momper; Alice M. Stek; Tim R. Cressey; Mark Mirochnick; Edmund V. Capparelli
1-Oct-2012Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeedingAdeniyi Olagunju; Andrew Owen; Tim R. Cressey
1-Jan-2020Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic ModelingXiaomei I. Liu; Jeremiah D. Momper; Natella Y. Rakhmanina; Dionna J. Green; Gilbert J. Burckart; Tim R. Cressey; Mark Mirochnick; Brookie M. Best; John N. van den Anker; André Dallmann